Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

RAPAd® CMV Adenoviral Expression System

Making an adenovirus with traditional recombinant methods takes 2-3 months and requires tedious plaque recombination. More recent technologies have shortened this time somewhat, but still produce relatively high amounts of wild type (replication-competent) plaques, levels of which increase with serial amplification. The RAPAd® Adenoviral Expression Systems produce recombinant adenovirus with substantially reduced wild-type virus, while considerably shortening the production time to 2-3 weeks. Serial amplification of adenovirus produced using the RAPAd® system does not significantly increase replication-competent adenovirus levels. The system uses a backbone vector from which the 5' ITR, packaging signal and E1 sequences have been removed.

Product Specifications

UNSPSC

41105908

Features & Benefits

Engineered to produce 100- to 10,000-fold fewer wild type plaques than most other expression systems; Generate high-titer virus in about 2-3 weeks compared to 2-3 months with other systems; Cloning capacity of shuttle vector = 6.9 kb

Shipping Conditions

Blue Ice

Storage Conditions

-20°C

Product Datasheet

Product MSDS

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

AUTS2 (NM_001127231) Human Tagged ORF Clone
RC226365 10 µg

AUTS2 (NM_001127231) Human Tagged ORF Clone

Ask
View Details
Fgf23 AAV siRNA Pooled Vector
20503166 1.0 μg

Fgf23 AAV siRNA Pooled Vector

Ask
View Details
Recombinant Human CREG1, N-His
MBS1572674-01 0.1 mg

Recombinant Human CREG1, N-His

Ask
View Details
Recombinant Human CREG1, N-His
MBS1572674-02 1 mg

Recombinant Human CREG1, N-His

Ask
View Details
Recombinant Human CREG1, N-His
MBS1572674-03 5x 1 mg

Recombinant Human CREG1, N-His

Ask
View Details